Dewpoint Therapeutics is the first company founded to apply the emerging discipline of biomolecular condensates to drug discovery. Dewpoint scientists are working in Boston, MA, and Dresden, Germany, to translate condensate biology into treatments for the toughest diseases. Vanderweil provided MEP/FP engineering services in support of a 27,000 sf fit-out including office rooms, office pods, various lab areas and support spaces, meeting rooms, cafe, wellness area, locker area, and storage space.

Dewpoint Therapeutics was the recipeint of IIDA New England’s Science & Research Small Award (2022)